A Study of Abilify® Tablet(Aripiprazole) as an Adjunctive Treatment in the Bipolar Depression
Clinical trial NCT03423680 · RECRUITING
Trial details
- NCT number
- NCT03423680
- Sponsor
- Korea Otsuka Pharmaceutical Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-22
- Primary completion
- 2025-11-01
- Enrollment
- 390
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.